376 related articles for article (PubMed ID: 16316392)
21. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
[TBL] [Abstract][Full Text] [Related]
22. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
[TBL] [Abstract][Full Text] [Related]
23. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
[TBL] [Abstract][Full Text] [Related]
24. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
25. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
Pollock RV; Carmichael LE
J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
[TBL] [Abstract][Full Text] [Related]
26. Passive protection of dogs against clinical disease due to Canine parvovirus-2 by specific antibody from chicken egg yolk.
Van Nguyen S; Umeda K; Yokoyama H; Tohya Y; Kodama Y
Can J Vet Res; 2006 Jan; 70(1):62-4. PubMed ID: 16548334
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.
Castro TX; Costa EM; Leite JP; Labarthe NV; Cubel Garcia RC
Res Vet Sci; 2011 Apr; 90(2):336-40. PubMed ID: 20609453
[TBL] [Abstract][Full Text] [Related]
28. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
29. A modified live canine parvovirus vaccine. II. Immune response.
Carmichael LE; Joubert JC; Pollock RV
Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
[TBL] [Abstract][Full Text] [Related]
30. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U
Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
[TBL] [Abstract][Full Text] [Related]
31. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
Hernández-Blanco B; Catala-López F
Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
33. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
[TBL] [Abstract][Full Text] [Related]
34. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
O'Brien SE
J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs.
Riedl M; Truyen U; Reese S; Hartmann K
Vet Rec; 2015 Dec; 177(23):597. PubMed ID: 26514756
[TBL] [Abstract][Full Text] [Related]
36. Canine parvovirus vaccination.
Atkinson M
Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
[No Abstract] [Full Text] [Related]
37. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine.
Pratelli A; Cavalli A; Martella V; Tempesta M; Decaro N; Carmichael LE; Buonavoglia C
Clin Diagn Lab Immunol; 2001 May; 8(3):612-5. PubMed ID: 11329467
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.
Martella V; Cavalli A; Decaro N; Elia G; Desario C; Campolo M; Bozzo G; Tarsitano E; Buonavoglia C
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1243-5. PubMed ID: 16210491
[TBL] [Abstract][Full Text] [Related]
39. Canine parvovirus infection: which diagnostic test for virus?
Desario C; Decaro N; Campolo M; Cavalli A; Cirone F; Elia G; Martella V; Lorusso E; Camero M; Buonavoglia C
J Virol Methods; 2005 Jun; 126(1-2):179-85. PubMed ID: 15847935
[TBL] [Abstract][Full Text] [Related]
40. Modified haemagglutination inhibition assay for the detection of canine parvovirus type 2 antibodies in dog sera.
Cavalli A; Martella V; Desario C; Camero M; Lanave G; Barrs VR; Decaro N; Buonavoglia C
Vet J; 2021 Aug; 274():105709. PubMed ID: 34157378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
